🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 20678X106
- IPO
- 2/3/2022 · $10.00/unit
- Previous Symbol
- MURF (changed 9/22/2023)
- Previous Name
- Murphy Canyon Acquisition Corp
Business: Conduit Pharmaceuticals Inc.is a multi-asset, clinical stage, disease-agnostic life science company delivering an efficient model for compound development. The Company both acquires and funds the development of Phase 2-ready assets and then seeks an exit through third-party license deals following successful clinical trials. The Company has developed a unique business model that allows it to act as a conduit to advance Phase 1 clinical assets from pharmaceutical companies through Phase 2, to develop new treatments for patients.
Company Contact
- CEO
- David Tapolczay
- CFO
- James Bligh
- Headquarters
- 4581 Tamiami Trail North, Suite 200 Naples, FL 34103
- Phone
- 646-491-9132
- Investor Relations
- 760-471-8536 · info@conduitpharma.com